KOSPICosmetics192820

Cosmax

₩295,500▲ 1.03%2026-11-18 close
Market Cap
₩3.4T
Turnover
₩28.4B
Volume
90K
Shares out.
11.4M
PER
14.6×
PBR
5.0×
EPS
₩19,206
Dividend Yield
1.18%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩3,300 per share · Prices as of the 2026-11-18 close

01

Report overview

Domestic orders and overseas gains converge; earnings volatility is the test

Cosmax recorded record quarterly sales of KRW 875.8 billion and operating profit of KRW 83.3 billion in 3Q 2026, but quarterly profit attributable to controlling shareholders has swung widely, making earnings durability the key item to watch.

  1. 1

    3Q 2026 sales reached KRW 875.8 billion, up 49.5% year on year, and operating profit reached KRW 83.3 billion, up 94.9%, with growth arriving in a seasonally weak quarter.

  2. 2

    Korea operations posted 3Q sales of KRW 616.1 billion, the first quarter above KRW 600 billion, and operating profit of KRW 67.7 billion, up 97%.

  3. 3

    The US unit's sales rose 88% to KRW 69.5 billion, and it has posted operating profit in two straight quarters since its first profitable quarter in 2Q 2026.

  4. 4

    Operating margin rose from 3.3% in 2022 to 8.2% in 2025, while the debt ratio stood at 247.1% at end-2025; quarterly profit attributable to controlling shareholders fell from KRW 85.1 billion in 4Q 2025 to KRW 41.6 billion in 1Q 2026.

  5. 5

    Shinhan Investment Corp. and Hana Securities presented target prices of KRW 410,000 and KRW 420,000 respectively in reports dated November 12, 2026.

02

Business structure

Cosmax is an original development and manufacturing (ODM) company for cosmetics, developing formulations and producing products on behalf of client brands. The company presents itself as a leading global cosmetics ODM player and emphasizes R&D and manufacturing capability as its core strengths.

Its operations consist of the Korea business and overseas units in China, the United States, Indonesia and Thailand. Korea operations' 3Q 2026 sales were KRW 616.1 billion, up 61% year on year, accounting for the bulk of consolidated sales of KRW 875.8 billion.

Product lines are split between skincare and color cosmetics. According to Shinyoung Securities, standalone skincare sales in 3Q 2026 reached KRW 431.3 billion, while color cosmetics sales rose 12% year on year, turning positive after five quarters.

Among overseas units, the Chinese operations (Shanghai and Guangzhou) grew sales 27% to KRW 177 billion. The US unit's sales rose 88% to KRW 69.5 billion, while Indonesia contributed KRW 28.8 billion and Thailand KRW 16.2 billion.

Clients are domestic and overseas cosmetics brands, and major clients' expanded online marketing and overseas distribution have driven orders. In competition, the company is compared with domestic ODM peers such as Kolmar Korea, and R&D speed and production scale are cited as the core of its bidding competitiveness.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩585.6B₩42.7B7.3%
2025Q4₩601B₩40.9B6.8%
2026Q1₩682B₩53B7.8%
2026Q2₩794.9B₩73.7B9.3%
2026Q3₩875.8B₩83.3B9.5%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩1.6T₩53.1B₩20.8B3.3%3.6%214.3%
2023₩1.8T₩115.7B₩57.1B6.5%15.8%334.3%
2024₩2.2T₩175.4B₩85.8B8.1%18.1%280.0%
2025₩2.4T₩195.8B₩123.1B8.2%22.0%247.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

Annual results show sales and profitability rising together. Sales grew from KRW 1.6 trillion in 2022 to KRW 2.4 trillion in 2025, the largest year in the 2022 to 2025 period. Operating profit rose from KRW 53.1 billion to KRW 195.8 billion, with the steepest gain of 117.9% in 2023.

Operating margin improved from 3.3% in 2022 to 8.2% in 2025.

Profit attributable to controlling shareholders grew from KRW 20.8 billion to KRW 123.1 billion, while net income including non-controlling interests moved from a net loss of KRW 16.4 billion in 2022 to net income of KRW 131.1 billion in 2025, a turnaround to profit.

The gap between the two measures reflects the non-controlling interest share. The debt ratio rose from 214.3% in 2022 to 334.3% in 2023 before easing to 247.1% in 2025.

At end-2025, total equity stood at KRW 612.3 billion, of which KRW 558.2 billion was attributable to controlling shareholders, and total liabilities were KRW 1.51 trillion.

Operating cash flow was KRW 102.5 billion in 2022, KRW 231 billion in 2023, KRW 73 billion in 2024 and KRW 86.7 billion in 2025, so cash generation fell in 2024 even as operating profit rose. Quarterly trends also improved.

Sales rose from KRW 585.6 billion in 3Q 2025 to KRW 875.8 billion in 3Q 2026, with four consecutive quarterly increases. Operating profit bottomed at KRW 40.9 billion in 4Q 2025 and then rose to KRW 53 billion, KRW 73.7 billion and KRW 83.3 billion over the next three quarters.

Operating margin in 3Q 2026 was about 9.5%, up 2.2 percentage points year on year. Profit attributable to controlling shareholders moved differently, from KRW 85.1 billion in 4Q 2025 to KRW 41.6 billion, KRW 48.7 billion and KRW 42.6 billion over the next three quarters. The last four quarters total KRW 217.9 billion. The composition of the 4Q 2025 profit spike requires checking non-operating items and income tax details.

05

Industry analysis

Cosmetics ODM demand moves with client brands' order volumes. 3Q 2026 is traditionally a weak season for the cosmetics industry, yet Korea operations recorded a record quarterly sales level, suggesting orders responded more to client expansion than to seasonality.

NH Investment & Securities estimated in an April 2026 report that Korean cosmetics exports rose 19% year on year in 1Q 2026, and the common industry explanation is that clients' overseas expansion is translating into more orders.

Brokers generally argue that domestic capacity expansion and better profitability at overseas units are combining to keep growth firm. Samsung Securities cited growth among top domestic skincare clients, direct exports and a recovery in color cosmetics as third-quarter drivers.

DB Financial Investment, however, noted in an April 2026 report that there was no new skincare-centred leading brand at the time. Viewed by cycle position, the period combines rising exports with clients' new product launches, but whether color or skincare leads changes the product mix and margins.

Against competitors, the company emphasizes the largest manufacturing and R&D scale in the industry and is compared with domestic ODM players such as Kolmar Korea. In China, the order flow from local color cosmetics clients is a variable to watch.

06

Outlook

The company has signaled that it intends to consolidate its position as the global cosmetics ODM leader, relying on R&D and manufacturing capability, rather than providing quantitative targets.

On production, expansion at the Pyeongtaek plant is under way during the year, and DB Financial Investment attributed the 3Q result to meeting rapidly rising orders with production. Broker estimates cover 4Q 2026 and 2027.

Hanwha Investment & Securities estimated 4Q 2026 sales of KRW 877.9 billion and operating profit of KRW 72.8 billion, and projected 2027 sales of KRW 3.882 trillion, up 20.2%, and operating profit of KRW 356.3 billion, up 25.9%.

Hana Securities raised its 2027 operating profit estimate from KRW 352.1 billion to KRW 381.8 billion on November 12, 2026. Shinhan Investment Corp. said it raised its 2027 estimate of profit attributable to controlling shareholders by 13%.

According to the Hanwha report, the US unit's 2027 operating margin target is in the high single digits, and Hanwha expects double-digit growth to continue at the Chinese, US and Southeast Asian units.

Because broker estimates differ, the 2026 annual results and the production trend after the Pyeongtaek expansion are the next points that will show which estimate is closer.

07

Valuation

PER
14.6×
PBR
5.0×
ROE
39.8%
EPS
₩19,206
BPS
₩56,278
Dividend per share
₩3,300

The current multiples should be read alongside the earnings trend. Operating profit rose from KRW 53.1 billion in 2022 to KRW 195.8 billion in 2025, while the price-to-book ratio sits in a range with a large premium over net asset value. Earnings have moved from a net loss to profit and continue to recover.

Broker assessments are comparatively favorable. Samsung Securities issued a Buy rating with a target of KRW 370,000 in a November 12, 2026 report, and Hanwha Investment & Securities and DB Financial Investment also presented KRW 370,000 on the same day.

Shinhan Investment Corp. presented KRW 410,000 and Hana Securities KRW 420,000. DB Financial Investment said the multiple looks attractive on its 2027 expected earnings.

Because quarterly profit attributable to controlling shareholders fluctuates widely, multiples should be interpreted together with the operating profit trend.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Domestic orders and expansion capacity

Korea operations' 3Q 2026 sales reached KRW 616.1 billion, the first quarter above KRW 600 billion, and operating profit rose 97% to KRW 67.7 billion. The company cites higher orders for higher-margin products such as essences and mists.

With the Pyeongtaek expansion under way, DB Financial Investment says capacity to convert rising orders into production is growing.

Profit improvement at the US and Southeast Asian units

The US unit posted its first profitable quarter in 2Q 2026 and kept operating profit positive in 3Q, when sales rose 88% to KRW 69.5 billion. Repeat orders from existing clients and rising skincare development requests drove the gain. Indonesian sales rose 34% and Thai sales rose 7%. According to the Hanwha report, the US unit's 2027 operating margin target is in the high single digits.

Upward revisions in broker estimates

Shinhan Investment Corp. raised its 2027 profit attributable to controlling shareholders estimate by 13%, while Hana Securities raised its 2027 operating profit estimate from KRW 352.1 billion to KRW 381.8 billion. Both cite domestic capacity expansion and the US unit's profitability. Hanwha Investment & Securities estimates 2027 operating profit at KRW 356.3 billion.

09

Bear factors

Volatility in quarterly net profit

Operating profit rose for three straight quarters from KRW 40.9 billion in 4Q 2025 to KRW 83.3 billion in 3Q 2026, yet profit attributable to controlling shareholders fell to KRW 41.6 billion in 1Q 2026 and then declined 12.6% quarter on quarter to KRW 42.6 billion in 3Q.

Because 4Q 2025 reached KRW 85.1 billion, the quarterly profit trend is hard to extrapolate. The source of the gap between operating profit and net profit needs confirmation.

Loss-making overseas units

The Chinese unit's 3Q sales rose 27% to KRW 177 billion, yet it posted a net loss of KRW 6.5 billion. The Indonesian unit swung to a net loss despite higher sales, and the Thai unit's net profit fell 34% year on year. Overseas sales growth has not translated into net profit gains at every unit.

Financial burden and cash generation

Total liabilities at end-2025 were KRW 1.51 trillion, exceeding total equity of KRW 612.3 billion, with a debt ratio of 247.1%. The ratio climbed from 214.3% in 2022 to 334.3% in 2023 before easing. Operating cash flow was KRW 73 billion in 2024 and KRW 86.7 billion in 2025, below KRW 231 billion in 2023. If the Pyeongtaek expansion accelerates, facility investment could add to financial pressure.

10

Risk factors

Client concentration and brand cycles

A large part of order growth depends on major clients' promotions and new product launches. In an April 2026 report, DB Financial Investment noted the absence of a new skincare-centred leading brand.

If clients change their marketing direction, order volumes can shift quickly, so client portfolio diversification matters.

Overseas profitability and currency

The US unit's profitability has existed for only two quarters, so its durability has yet to be tested over a longer period. The Chinese unit grew sales but posted a net loss. Overseas results are translated into won, so exchange-rate swings affect consolidated profit more as the overseas share grows.

Capacity investment and leverage

The Pyeongtaek expansion adds production capacity but brings fixed costs and facility investment. At a debt ratio of 247.1% at end-2025, how expansion is funded and how fast operating cash flow recovers both matter. If utilization lags order growth, margins could come under pressure.

11

What to watch next

  1. Early February 2027 (expected)

    Release of 4Q 2026 and full-year 2026 preliminary results. This is the point to check the composition of 4Q profit attributable to controlling shareholders and whether operating margin holds in the 8% range.

  2. By March 31, 2027

    Deadline for the 2026 annual report. It is the point to confirm final annual results, year-end debt structure and the detailed items behind 4Q net profit using the regular report figures.

  3. First half of 2027

    Operation of the expanded Pyeongtaek plant. This is the point to check whether added capacity converts into domestic order growth and operating profit.

  4. By May 15, 2027

    Deadline for the 1Q 2027 quarterly report. It is the point to see whether the US unit keeps posting operating profit and whether the Chinese unit's net loss narrows.

  5. By August 14, 2027

    Deadline for the 2027 half-year report. It is the point to compare progress against 2027 operating profit estimates of KRW 356.3 billion from Hanwha Investment & Securities and KRW 381.8 billion from Hana Securities.

12

Overall view

Cosmax's public results for 2022 to 2025 show sales, operating profit and profit attributable to controlling shareholders each rising for three consecutive years, with operating margin improving from 3.3% to 8.2%.

In 3Q 2026, sales of KRW 875.8 billion and operating profit of KRW 83.3 billion set a record quarterly sales level, led by Korea operations and the US unit. Some overseas units, including China and Indonesia, remain in net loss positions.

Profit attributable to controlling shareholders moved from KRW 85.1 billion in 4Q 2025 to KRW 41.6 billion in 1Q 2026 and KRW 42.6 billion in 3Q, a wide quarterly range.

On the balance sheet, the debt ratio was 247.1% at end-2025, above 214.3% in 2022, and operating cash flow fell to KRW 73 billion in 2024 before recovering to KRW 86.7 billion in 2025.

Several brokers presented target prices in their November 12, 2026 reports, but these are each firm's assessments and should be read apart from reported results.

The next checkpoints are the operating margin in the 2026 annual results, the operating pattern after the Pyeongtaek expansion, and whether overseas units turn their net results positive.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 13 more articles and sources
  1. digitaltoday.co.kr
  2. cosmorning.com
  3. businesspost.co.kr
  4. view.asiae.co.kr
  5. m.news.nate.com
  6. m.news.nate.com
  7. inthenews.co.kr
  8. news.nate.com
  9. m.news.nate.com
  10. news.nate.com
  11. starnewskorea.com
  12. news.nate.com
  13. newspim.com

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis